Novel leptin receptor signaling mutants identify location and sex-dependent modulation of bone density, adiposity, and growth.


Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 04 2018
accepted: 29 08 2018
pubmed: 1 10 2018
medline: 19 3 2020
entrez: 1 10 2018
Statut: ppublish

Résumé

Leptin, a hormone primarily produced by adipocytes, contributes to the regulation of bone health by modulating bone density, growth and adiposity. Upon leptin binding, multiple sites of the long form of the leptin receptor (LepRb) are phosphorylated to trigger activation of downstream signaling pathways. To address the role of LepRb-signaling pathways in bone health, we compared the effects of three LepRb mutations on bone density, adiposity, and growth in male and female mice. The ∆65 mutation, which lacks the known tyrosine phosphorylation sites, caused obesity and the most dramatic bone phenotype marked by excessive bone adiposity, osteoporosis, and decreased growth, consistent with the phenotype of db/db and ob/ob mice that fully lack leptin receptor signaling. Mutation of LepRb Tyr

Identifiants

pubmed: 30269370
doi: 10.1002/jcb.27726
pmc: PMC6336499
mid: NIHMS987817
doi:

Substances chimiques

Leptin 0
Receptors, Leptin 0
Socs3 protein, mouse 0
Suppressor of Cytokine Signaling 3 Protein 0
Protein Tyrosine Phosphatase, Non-Receptor Type 11 EC 3.1.3.48

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4398-4408

Subventions

Organisme : NIDCR NIH HHS
ID : R00 DE024178
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT007695
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK056731
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK101050
Pays : United States

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

J Clin Invest. 2007 May;117(5):1354-60
pubmed: 17415414
Bone. 2005 Nov;37(5):607-21
pubmed: 16039170
Bone. 2004 Mar;34(3):376-83
pubmed: 15003785
Endocrinology. 2003 May;144(5):2121-31
pubmed: 12697721
J Bone Miner Res. 2010 Feb;25(2):298-304
pubmed: 19653811
Biochimie. 2012 Oct;94(10):2089-96
pubmed: 22534195
J Bone Miner Res. 2004 Oct;19(10):1607-11
pubmed: 15355554
J Bone Miner Res. 2001 Aug;16(8):1426-33
pubmed: 11499865
Bone. 2004 Mar;34(3):369-71
pubmed: 15003783
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):303-8
pubmed: 18403928
J Endocrinol. 2018 Feb;236(2):57-68
pubmed: 29191939
J Bone Miner Res. 2017 May;32(5):974-984
pubmed: 28029186
Stem Cells. 2010 Jun;28(6):1071-80
pubmed: 20506495
J Endocrinol. 2002 Nov;175(2):405-15
pubmed: 12429038
Cell Stem Cell. 2014 Aug 7;15(2):154-68
pubmed: 24953181
J Biol Chem. 2007 Oct 19;282(42):31019-27
pubmed: 17726024
Endocrinology. 1999 Apr;140(4):1630-8
pubmed: 10098497
Nature. 2003 Feb 20;421(6925):856-9
pubmed: 12594516
Cell Metab. 2006 Nov;4(5):341-8
pubmed: 17084709
Nature. 2005 Mar 24;434(7032):514-20
pubmed: 15724149
Endocrinology. 2004 Jan;145(1):447-52
pubmed: 14525917
Regul Pept. 2006 Sep 11;136(1-3):9-13
pubmed: 16764953
Diabetes. 2010 Apr;59(4):782-90
pubmed: 20068132
Nat Rev Rheumatol. 2017 Feb;13(2):100-109
pubmed: 28053336
J Bone Miner Res. 2005 Jun;20(6):994-1001
pubmed: 15883640
J Bone Miner Res. 2011 Jul;26(7):1506-16
pubmed: 21328617
J Bone Miner Res. 2011 Aug;26(8):1698-709
pubmed: 21328476
Peptides. 2007 May;28(5):1012-9
pubmed: 17346852
J Bone Miner Res. 2010 Sep;25(9):2078-88
pubmed: 20229598
Front Endocrinol (Lausanne). 2016 Aug 16;7:110
pubmed: 27579023
Cell Tissue Res. 2007 Jan;327(1):133-41
pubmed: 17024416
Regul Pept. 2000 Aug 25;92(1-3):73-8
pubmed: 11024568
J Cell Physiol. 2009 Feb;218(2):376-84
pubmed: 18932203
J Bone Miner Res. 2013 Jan;28(1):22-34
pubmed: 22887758
J Biol Chem. 2000 May 12;275(19):14563-72
pubmed: 10799542
Cell Stem Cell. 2016 Jun 2;18(6):782-96
pubmed: 27053299
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S8-12
pubmed: 19136996

Auteurs

Ian C McCabe (IC)

Department of Physiology, Michigan State University, East Lansing, Michigan.

Alyssa Fedorko (A)

Department of Physiology, Michigan State University, East Lansing, Michigan.

Martin G Myers (MG)

Department of Molecular and Integrative Physiology, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan.
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Gina Leinninger (G)

Department of Physiology, Michigan State University, East Lansing, Michigan.

Erica Scheller (E)

Department of Medicine, Division of Bone and Mineral Diseases, Washington University, Saint Louis, Missouri.

Laura R McCabe (LR)

Department of Physiology, Michigan State University, East Lansing, Michigan.
Department of Radiology, Michigan State University, East Lansing, Michigan.
Biomedical Imaging Research Center, Michigan State University, East Lansing, Michigan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH